Cindy Eckert

Cindy Eckert is a prominent entrepreneur and advocate in women's health, best known for her role in developing Addyi, the first FDA-approved medication for women with hypoactive sexual desire disorder (HSDD). After facing multiple challenges, including a contentious battle with the FDA and criticism for her marketing strategies, Eckert successfully regained ownership of her company, Sprout Pharmaceuticals, in 2018. Under her leadership, Addyi has gained significant traction, with an increasing number of prescriptions and a growing cultural conversation around women's sexual health. Eckert is also a vocal advocate for gender parity in healthcare, challenging the disparity in how treatments for women's health conditions are covered compared to those for men.